185 related articles for article (PubMed ID: 35077844)
1. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
[TBL] [Abstract][Full Text] [Related]
2. The combination of machine learning and transcriptomics reveals a novel megakaryopoiesis inducer, MO-A, that promotes thrombopoiesis by activating FGF1/FGFR1/PI3K/Akt/NF-κB signaling.
Zhang T; Mo Q; Jiang N; Wu Y; Yang X; Chen W; Li Q; Yang S; Yang J; Zeng J; Huang F; Huang Q; Luo J; Wu J; Wang L
Eur J Pharmacol; 2023 Apr; 944():175604. PubMed ID: 36804544
[TBL] [Abstract][Full Text] [Related]
3. Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.
Jiang X; Sun Y; Yang S; Wu Y; Wang L; Zou W; Jiang N; Chen J; Han Y; Huang C; Wu A; Zhang C; Wu J
Phytomedicine; 2023 Feb; 110():154637. PubMed ID: 36610353
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia.
Shin J; Kim MJ; Quan X; Kim JW; Lee S; Park S; Jeong JY; Yea K
BMC Cancer; 2023 May; 23(1):490. PubMed ID: 37259024
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia potentiates megakaryocyte differentiation and thrombopoiesis via GH-PI3K-Akt axis.
Lei W; Liu Z; Su Z; Meng P; Zhou C; Chen X; Hu Z; Xiao A; Zhou M; Huang L; Zhang Y; Qin X; Wang J; Zhu F; Nie J
J Hematol Oncol; 2023 Jul; 16(1):84. PubMed ID: 37501059
[TBL] [Abstract][Full Text] [Related]
6. Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
Wang L; Liu S; Luo J; Mo Q; Ran M; Zhang T; Li X; Zou W; Mei Q; Chen J; Yang J; Zeng J; Huang F; Wu A; Zhang C; Wu J
Haematologica; 2023 May; 108(5):1394-1411. PubMed ID: 36546424
[TBL] [Abstract][Full Text] [Related]
7. A Novel Antithrombocytopenia Agent,
Chen W; Zhu L; Wang L; Zeng J; Wen M; Xu X; Zou L; Huang F; Huang Q; Qin D; Mei Q; Yang J; Wang Q; Wu J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430539
[TBL] [Abstract][Full Text] [Related]
8. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
9. Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.
Zhou L; Ni C; Liao R; Tang X; Yi T; Ran M; Huang M; Liao R; Zhou X; Qin D; Wang L; Huang F; Xie X; Wan Y; Luo J; Wang Y; Wu J
Elife; 2024 Apr; 13():. PubMed ID: 38573820
[TBL] [Abstract][Full Text] [Related]
10. Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout.
Hitchcock IS; Fox NE; Prévost N; Sear K; Shattil SJ; Kaushansky K
Blood; 2008 Jan; 111(2):596-604. PubMed ID: 17925492
[TBL] [Abstract][Full Text] [Related]
11. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
[TBL] [Abstract][Full Text] [Related]
12. M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity.
Zhao HY; Zhang YY; Xing T; Tang SQ; Wen Q; Lyu ZS; Lv M; Wang Y; Xu LP; Zhang XH; Kong Y; Huang XJ
Signal Transduct Target Ther; 2021 Jun; 6(1):234. PubMed ID: 34140465
[TBL] [Abstract][Full Text] [Related]
13. Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL.
Kozuma Y; Kojima H; Yuki S; Suzuki H; Nagasawa T
J Thromb Haemost; 2007 Jun; 5(6):1274-82. PubMed ID: 17389006
[TBL] [Abstract][Full Text] [Related]
14. PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1).
Nakao T; Geddis AE; Fox NE; Kaushansky K
Cell Cycle; 2008 Jan; 7(2):257-66. PubMed ID: 18256550
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts.
Hacein-Bey-Abina S; Estienne M; Bessoles S; Echchakir H; Pederzoli-Ribeil M; Chiron A; Aldaz-Carroll L; Leducq V; Zhang Y; Souyri M; Louache F; Abina AM
Exp Hematol; 2020 Aug; 88():15-27. PubMed ID: 32721504
[TBL] [Abstract][Full Text] [Related]
16. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes.
Miyakawa Y; Rojnuckarin P; Habib T; Kaushansky K
J Biol Chem; 2001 Jan; 276(4):2494-502. PubMed ID: 11054408
[TBL] [Abstract][Full Text] [Related]
18.
Yang X; Wang L; Zeng J; Wu A; Qin M; Wen M; Zhang T; Chen W; Mei Q; Qin D; Yang J; Jiang Y; Wu J
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297316
[TBL] [Abstract][Full Text] [Related]
19. DMAG, a novel countermeasure for the treatment of thrombocytopenia.
Lin J; Zeng J; Liu S; Shen X; Jiang N; Wu YS; Li H; Wang L; Wu JM
Mol Med; 2021 Nov; 27(1):149. PubMed ID: 34837956
[TBL] [Abstract][Full Text] [Related]
20. The role of platelet factor 4 in radiation-induced thrombocytopenia.
Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
